Improving HIV testing and treatment for mothers and newborns in Tanzania and Mozambique
Official title: Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
Run by Ludwig-Maximilians - University of Munich · NCT06267508 · Data updated 2026-11-12
This study is trying to improve HIV testing and treatment for mothers and their newborns in Tanzania and Mozambique to help prevent the virus from passing from mother to child.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 6000 (estimated) |
| Sponsor | Ludwig-Maximilians - University of Munich Academic / other |
| Locations | 2 sites (Beira and 1 other locations) |
| Status | Recruiting |
| Started | April 30, 2024 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | November 18, 2024 |
| Trial ID | NCT06267508 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include mothers living with HIV who are willing to consent to HIV testing for themselves and their newborns.
✕Probably not a fit
Patients who have delivered more than 72 hours ago or those with emergency medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance HIV healthcare services for mothers living with HIV and their newborns in Tanzania and Mozambique. It focuses on improving screening through maternal HIV viral load monitoring at delivery to identify high-risk mother-child pairs for vertical transmission. The study will implement a hub-and-spoke referral system to expand access to HIV testing services in rural areas. By optimizing treatment and prevention interventions, the study seeks to translate previous research findings into effective policy and practice.
Why it matters
Potential benefit: If successful, this study could significantly reduce new pediatric HIV infections and improve health outcomes for infants and mothers.
How similar studies have gone: Previous studies have shown success in identifying and treating HIV in neonates, indicating that this approach has potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Voluntary and informed consent of the mother for her own study participation (if applicable); 2. Voluntary and informed consent of the legal guardian of the child for participation of the child in the study; 3. Mothers/legal guardians ≥18 years of age; 4. Documented maternal HIV infection; 5. Willingness to consent to HIV testing for the child and herself (or just her child); and 6. Willingness to consent to active tracing including home tracing. Exclusion Criteria: 7. Deficiency in the mother, rendering it difficult, if not impossible, for her or her infant to take part in the study or understand the information provided to her. 8. Having delivered more than 72h (3 days) ago; 9. Prisoners; 10. Women presenting with an emergency requiring immediate medical assistance if not resolved at study inclusion; 11. Stillbirths; 12. Infant requiring emergency care (e.g. immediate or rapid occurring life threatening conditions, resuscitation, prolonged obstetric related intensive care, severe jaundice) or born with severe malformation; 13. If within the discretion of the investigator based on recommendation of the gynaecologist or paediatrician in charge study participation would possibly add not acceptable risk or burden to the mother or infant (e.g. significant congenital malformation, health deficiencies, very low birth weight less than 1500g); or 14. Unlikely to comply with protocol as judged by the principal investigator or his designate
Where it's running
-
Centro de Investigacao Operacional de Beira (CIOB), Instituto Nacional de Saúde (INS), Ministério da Saúde,
Beira, Mozambique Recruiting -
National Institute for Medical Research (NIMR)
Mbeya, Mbeya, Tanzania Recruiting
Study contacts
- Study coordinator: Arne Kroidl, MD
- Email: Arne.Kroidl@med.uni-muenchen.de
- Phone: +49-89-4400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Monitoring vital signs of newborns using advanced wireless sensors
This study is testing a new wireless sensor to see if it can safely and accurately monitor the vital signs of healthy newborns during their first two hours after birth compared to the traditional wired system.
-
Walk With Me for Perinatal Grief
A mobile app-based program (Along With Me) with or without a Peer Guide is tested to see if it lowers posttraumatic stress and suicidal thoughts in bereaved parents after pregnancy or early infant loss.
-
How higher temperatures affect pregnant women and newborns in rural Sindh
This cohort will test whether exposure to high environmental temperatures during pregnancy increases the chances of early birth, low birth weight, or other complications for pregnant women in rural Sindh.
-
Evaluating chest physiotherapy for infants with bronchiolitis
This study tests if chest physiotherapy given by mothers can help infants under 12 months with bronchiolitis feel better compared to just standard hospital care.
-
Testing platelet transfusion thresholds in extremely preterm infants
This study is testing if giving platelet transfusions at a lower level can help extremely premature babies survive without major bleeding during their first week of life.
-
TodaysBaby mobile safe-sleep support for new parents
This program tests the TodaysBaby mobile safe-sleep messaging for parents of healthy, full-term newborns to see if it improves safe sleep practices and reaches families equally across income and race/ethnicity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.